Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details)

v3.21.1
Net (Loss) Income Per Share (Schedule Of Earnings Per Share, Basic And Diluted) (Details) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2021
Mar. 31, 2020
Schedule of Earnings Per Share, Basic and Diluted [Line Items]            
Net (loss) income $ (2,845,981) $ 17,227,701 $ (810,509) $ (3,305,101) $ 14,381,720 $ (4,115,610)
Basic weighted average common shares outstanding 75,175,077   65,367,493   72,717,621 65,202,103
Common stock purchase warrants         744,821  
Total net effect of dilutive instruments         7,936,449  
Diluted weighted average common shares outstanding 75,175,077   65,367,493   80,654,070 65,202,103
Net (loss) income per basic common share outstanding $ (0.04)   $ (0.01)   $ 0.20 $ (0.06)
Net (loss) income per diluted common share outstanding $ (0.04)   $ (0.01)   $ 0.18 $ (0.06)
Stock Options [Member]            
Schedule of Earnings Per Share, Basic and Diluted [Line Items]            
Net effect of dilutive instruments         7,147,372  
Stock Appreciation Rights (SARs) [Member]            
Schedule of Earnings Per Share, Basic and Diluted [Line Items]            
Net effect of dilutive instruments         44,256